Optimizing transfusion therapy for survivors of Haemoglobin Bart's hydrops fetalis syndrome: Defining the targets for haemoglobin‐H fraction and “functional” haemoglobin level
Authors:
- 17 February 2022
- journal article
- research article
- Published by Wiley in British Journal of Haematology
- Vol. 197 (3) , 373-376
Abstract
Owing to the unique pathophysiology of anaemia in haemoglobin Bart's hydrops fetalis (HBHF), a transfusion strategy based on beta-thalassemia guidelines is suboptimal for chronically transfused HBHF patients. A more aggressive transfusion aimed at reducing the proportion of non-functional HbH and improving the “functional” haemoglobin (f-Hb) can lead to reduced haemolysis and improved tissue oxygenation. However, the optimal transfusion targets for these parameters are not yet defined. In this retrospective, longitudinal study on four chronically transfused patients with HBHF, we used receiver operating characteristic curves to find a pre-transfusion f-Hb of 106 g/l and a HbH of 16.1% to be the optimal thresholds to achieve a normal soluble transferrin receptor and lactate dehydrogenase, respectively.Keywords
This publication has 11 references indexed in Scilit:
- Outcomes of haemoglobin Bart’s hydrops fetalis following intrauterine transfusion in Ontario, CanadaArchives of Disease in Childhood - Fetal and Neonatal Edition, 2020
- Management of haemoglobin Barts hydrops fetalis syndrome with exchange transfusionsInternal Medicine Journal, 2020
- Iron overload in transfusion-dependent survivors of hemoglobin Bart’s hydrops fetalisHaematologica, 2018
- Optimizing chronic transfusion therapy for survivors of hemoglobin Barts hydrops fetalisBlood, 2016
- The α-ThalassemiasNew England Journal of Medicine, 2014
- Transfusion suppresses erythropoiesis and increases hepcidin in adult patients with β-thalassemia major: a longitudinal studyBlood, 2013
- The Pathophysiology and Clinical Features of α Thalassaemia2009
- Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell diseaseBlood, 2006
- Hydrops Fetalis Caused by α-Thalassemia: An Emerging Health Care ProblemBlood, 1998
- A moderate transfusion regimen may reduce iron loading in beta‐ thalassemia major without producing excessive expansion of erythropoiesisTransfusion, 1997